Clinical organ toxicity of antiarrhythmic compounds: ocular and pulmonary manifestations (Q33777260)

29 July 2017

1 reference

title

Clinical organ toxicity of antiarrhythmic compounds: ocular and pulmonary manifestations (English)

1 reference

29 July 2017

Pollak PT

1

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

American Journal of Cardiology

29 July 2017

published in

1 reference

29 July 2017

volume

84

1 reference

29 July 2017

issue

9A

1 reference

29 July 2017

page(s)

37R-45R

1 reference

An account of the foxglove, and some of its medical uses:with practical remarks on dropsy, and other diseases

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900700-6

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900700-6

Antiarrhythmic drug therapy in the treatment of atrial fibrillation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900700-6

Untoward effects associated with practolol administration: oculomucocutaneous syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900700-6

Amiodarone keratopathy: drug-induced lipid storage disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900700-6

Amiodarone induced cornea verticillata

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900700-6

Clinical experience and grading of amiodarone keratopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900700-6

Correlation of amiodarone dosage, heart rate, QT interval and corneal microdeposits with serum amiodarone and desethylamiodarone concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900700-6

Retinal maculopathy possibly associated with amiodarone medication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900700-6

Optic neuropathy and amiodarone therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900700-6

Bilateral optic neuropathy following amiodarone therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900700-6

Enlargement of extraocular muscles during treatment with amiodarone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900700-6

Pseudotumor cerebri as a complication of amiodarone therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900700-6

Progression of amiodarone induced cataracts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900700-6

Ocular effects in long-term amiodarone therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900700-6

Ocular side effects of amiodarone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900700-6

Possible association of pneumonitis with amiodarone therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900700-6

Amiodarone pulmonary toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900700-6

Amiodarone and chronic lung fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900700-6

Long-term low-dose amiodarone therapy in the management of ventricular and supraventricular tachyarrhythmias: efficacy and safety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900700-6

Adverse effects of low dose amiodarone: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900700-6

Bronchiolitis obliterans organizing pneumonia secondary to amiodarone: a rare aetiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900700-6

Bronchiolitis obliterans organizing pneumonia during low-dose amiodarone therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900700-6

Amiodarone-induced bronchiolitis obliterans organizing pneumonia (BOOP)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900700-6

Amiodarone pneumonitis: no safe dose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900700-6

Amiodarone lung toxicity: a human and experimental study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900700-6

Amiodarone pulmonary toxicity: Prospective evaluation of serial pulmonary function tests

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900700-6

Amiodarone and multilamellar inclusion bodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900700-6

Steady-state serum amiodarone concentrations: relationships with antiarrhythmic efficacy and toxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900700-6

Pulmonary fibrosis induced in the hamster by amiodarone and desethylamiodarone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900700-6

Prospective evaluation of amiodarone pulmonary toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900700-6

Amiodarone and its desethyl metabolite: tissue distribution and morphologic changes during long-term therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900700-6

Role of phospholipase A inhibition in amiodarone pulmonary toxicity in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900700-6

Amiodarone pharmacokinetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900700-6

Relation of amiodarone hepatic and pulmonary toxicity to serum drug concentrations and superoxide dismutase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900700-6

Acute necrotizing pneumonitis and hyperglycemia after amiodarone therapy. Case report and review of amiodarone-associated pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900700-6

Amiodarone pulmonary toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900700-6

Granular cells as a marker of early amiodarone hepatotoxicity: a pathological and analytical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900700-6

Amiodarone-induced pulmonary fibrosis in hamsters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900700-6

Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900700-6

Reductive metabolism of nitrofurantoin by rat lung and liver in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900700-6

Oxygen metabolite detoxifying enzyme levels in bleomycin-induced fibrotic lungs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900700-6

Curcumin protects bleomycin-induced lung injury in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900700-6

Toxic Effects of the Herbicide Paraquat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900700-6

Danger of amiodarone therapy and elevated inspired oxygen concentrations in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900700-6

Toxicity of amiodarone on mouse pulmonary endothelial cells cultured with or without alveolar macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900700-6

Evaluation of reactive oxygen species involvement in amiodarone pulmonary toxicity in vivo and in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900700-6

Amiodarone-induced disruption of hamster lung and liver mitochondrial function: lack of association with thiobarbituric acid-reactive substance production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900700-6

Drug-induced lupus: clinical spectrum and pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900700-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9149(99)00700-6

1 reference

29 July 2017

1 reference